Akorn (AKRX) was downgraded to hold at Deutsche Bank. $24 price target. Earnings estimates were also cut, given lower expected ephedrine sales, Deutsche said.
Albermarle (ALB) was downgraded to neutral from Citigroup. $112 price target. The company is already valued at 18x expected 2018 EBITDA, Citi said.
Dow Chemical (DOW) was upgraded to buy from hold at Jefferies. $75 price target. The merger creates multiple growth levers, Jefferies said.
FedEx (FDX) was upgraded to outperform at BMO Capital. $220 price target. The company is leveraged to an improving domestic industrial outlook, BMO said.
GoPro (GPRO) was downgraded to sell from neutral at Goldman Sachs. $6 price target. The company is facing challenges and burning through cash, Goldman said.
Garmin (GRMN) was upgraded to neutral from sell at Goldman Sachs. $52 price target. The valuation is more attractive, as consensus estimates appear to have bottomed out, Goldman said.
HP (HPQ) was upgraded to outperform at Wells Fargo. Supplies growth and margin expansion could drive earnings upside, Wells said.
Universal Health (UHS) was upgraded to overweight from neutral at Piper Jaffray. $147 price target. The company has multiple growth levers, Piper said.
United Therapeutics (UTHR) was downgraded to underperform from hold at Jefferies. $116 price target. A poll suggests potential competitive headwinds, Jefferies said.